tungstate has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, J | 1 |
| Barberà, A; Domínguez, J; Fernàndez-Alvarez, J; Gomis, R; Guinovart, JJ; Muñoz, MC | 1 |
2 other study(ies) available for tungstate and Diabetes Mellitus
| Article | Year |
|---|---|
Vanadate, molybdate and tungstate for orthomolecular medicine.
Topics: Adipocytes; Animals; Diabetes Mellitus; Humans; Liver; Molybdenum; Orthomolecular Therapy; Protein-Tyrosine Kinases; Rats; Receptor, Insulin; Tungsten Compounds; Vanadates | 1994 |
Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats.
Topics: Administration, Oral; Animals; Diabetes Mellitus; Glucose-6-Phosphate; Glycogen; Hyperglycemia; Hypoglycemic Agents; Islets of Langerhans; Liver; Male; Obesity; Phosphorylation; Rats; Rats, Zucker; Tungsten Compounds; Tyrosine | 2001 |